Perception is a gene therapy company based in the San Francisco Bay Area
To accelerate the clinical translation of gene therapy by reinventing its development and manufacturing.
|Omid Karkouti, MS
Founder and CEO
Omid has worked in the Life Sciences industry for over 10 years, first as a researcher and later as a business leader, and holds a M.S. in Molecular Virology from Baylor College of Medicine. As a rare disease patient advocate, Omid founded Perception to create scalable infrastructure that enables the development of gene therapies for thousands of previously untreatable genetic diseases.
|Elizabeth Iorns, PhD
Co-founder, Board Director
Dr. Elizabeth Iorns is the Founder & CEO of Science Exchange, the Co-Director of the Reproducibility Initiative, and is a part-time partner at Y Combinator. Elizabeth has a Ph.D. in Cancer Biology from the Institute of Cancer Research (UK). Elizabeth has received a range of honors and recognition, including ranking as one of Nature Magazine’s ‘Ten People Who Mattered’ and one of WIRED’s ‘50 Women Who Are Changing The World’.
Our team has deep industry expertise in automation, virology, cancer biology, drug development, manufacturing, regulatory, software product, BD, and marketing.